CALERES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CALERES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Feb 2, 2019 | $85.51M | Apr 3, 2019 |
| FY2018 | Feb 3, 2018 | $85.12M | Apr 3, 2019 |
| FY2018 | Jan 28, 2017 | $91.42M | Apr 3, 2019 |
| FY2017 | Jan 30, 2016 | $100.19M | Apr 4, 2018 |
| FY2016 | Jan 31, 2015 | $114.41M | Mar 28, 2017 |
| FY2015 | Feb 1, 2014 | $132.60M | Mar 29, 2016 |
| FY2014 | Feb 2, 2013 | $2.48B | Apr 1, 2015 |
| FY2013 | Jan 28, 2012 | $2.43B | Apr 1, 2014 |
| FY2012 | Jan 29, 2011 | $2.50B | Apr 2, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.18B | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $1.22B | Apr 2, 2026 |
| FY2025 | Feb 3, 2024 | $1.26B | Apr 2, 2026 |
| FY2024 | Jan 28, 2023 | $1.28B | Apr 1, 2025 |
| FY2023 | Jan 29, 2022 | $1.23B | Apr 2, 2024 |
| FY2022 | Jan 30, 2021 | $787.05M | Mar 28, 2023 |
| FY2019 | Feb 1, 2020 | $278.81M | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | $319.77M | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | $305.94M | Mar 31, 2020 |
| FY2019 | May 4, 2019 | $279.84M | Mar 31, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | ($6.69M) | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $107.26M | Apr 2, 2026 |
| FY2025 | Feb 3, 2024 | $171.39M | Apr 2, 2026 |
| FY2024 | Jan 28, 2023 | $181.74M | Apr 1, 2025 |
| FY2023 | Jan 29, 2022 | $137.02M | Apr 2, 2024 |
| FY2022 | Jan 30, 2021 | ($439.11M) | Mar 28, 2023 |
| FY2019 | Feb 1, 2020 | $408.0K | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | $27.99M | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | $25.34M | Mar 31, 2020 |
| FY2019 | May 4, 2019 | $9.08M | Mar 31, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $6.37M | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $149.86M | Apr 2, 2026 |
| FY2025 | Feb 3, 2024 | $194.46M | Apr 2, 2026 |
| FY2024 | Jan 28, 2023 | $214.33M | Apr 1, 2025 |
| FY2023 | Jan 29, 2022 | $205.81M | Apr 2, 2024 |
| FY2022 | Jan 30, 2021 | ($485.66M) | Mar 28, 2023 |
| FY2021 | Feb 1, 2020 | $103.81M | Mar 28, 2022 |
| FY2020 | Feb 2, 2019 | $401.0K | Mar 30, 2021 |
| FY2019 | Feb 3, 2018 | $127.68M | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $95.99M | Apr 3, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.16B | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $1.07B | Apr 2, 2026 |
| FY2025 | Feb 3, 2024 | $1.06B | Apr 2, 2026 |
| FY2024 | Jan 28, 2023 | $1.07B | Apr 1, 2025 |
| FY2023 | Jan 29, 2022 | $1.01B | Apr 2, 2024 |
| FY2022 | Jan 30, 2021 | $889.49M | Mar 28, 2023 |
| FY2021 | Feb 1, 2020 | $1.07B | Mar 28, 2022 |
| FY2020 | Feb 2, 2019 | $1.04B | Mar 30, 2021 |
| FY2019 | Feb 3, 2018 | $1.04B | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $942.60M | Apr 3, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $103.18M | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $104.56M | Apr 2, 2026 |
| FY2025 | Feb 3, 2024 | $200.15M | Apr 2, 2026 |
| FY2024 | Jan 28, 2023 | $125.88M | Apr 1, 2025 |
| FY2023 | Jan 29, 2022 | $168.44M | Apr 2, 2024 |
| FY2022 | Jan 30, 2021 | $126.35M | Mar 28, 2023 |
| FY2021 | Feb 1, 2020 | $170.79M | Mar 28, 2022 |
| FY2020 | Feb 2, 2019 | $129.59M | Mar 30, 2021 |
| FY2019 | Feb 3, 2018 | $191.38M | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $183.62M | Apr 3, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $63.74M | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $49.15M | Apr 2, 2026 |
| FY2025 | Feb 3, 2024 | $44.58M | Apr 2, 2026 |
| FY2024 | Jan 28, 2023 | $55.91M | Apr 1, 2025 |
| FY2023 | Jan 29, 2022 | $18.39M | Apr 2, 2024 |
| FY2022 | Jan 30, 2021 | $16.79M | Mar 28, 2023 |
| FY2021 | Feb 1, 2020 | $44.53M | Mar 28, 2022 |
| FY2020 | Feb 2, 2019 | $62.48M | Mar 30, 2021 |
| FY2019 | Feb 3, 2018 | $44.72M | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $50.52M | Apr 3, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.97B | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $1.89B | Apr 2, 2026 |
| FY2025 | Feb 3, 2024 | $1.80B | Apr 2, 2026 |
| FY2024 | Jan 28, 2023 | $1.84B | Apr 1, 2025 |
| FY2023 | Jan 29, 2022 | $1.84B | Apr 2, 2024 |
| FY2022 | Jan 30, 2021 | $1.87B | Mar 28, 2023 |
| FY2021 | Feb 1, 2020 | $2.43B | Mar 28, 2022 |
| FY2020 | Feb 2, 2019 | $1.84B | Mar 30, 2021 |
| FY2019 | Feb 3, 2018 | $1.49B | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $1.48B | Apr 3, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $601.85M | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $599.02M | Apr 2, 2026 |
| FY2024 | Feb 3, 2024 | $560.63M | Apr 1, 2025 |
| FY2023 | Jan 28, 2023 | $420.68M | Apr 2, 2024 |
| FY2022 | Jan 29, 2022 | $318.57M | Mar 28, 2023 |
| FY2021 | Jan 30, 2021 | $200.25M | Mar 28, 2022 |
| FY2020 | Feb 1, 2020 | $645.95M | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | $634.05M | Mar 31, 2020 |
| FY2018 | Feb 3, 2018 | $717.49M | Apr 3, 2019 |
| FY2017 | Jan 28, 2017 | $613.12M | Apr 4, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $15.39M | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $4.96M | Apr 2, 2026 |
| FY2024 | Feb 3, 2024 | $4.96M | Apr 1, 2025 |
| FY2023 | Jan 28, 2023 | $4.96M | Apr 2, 2024 |
| FY2022 | Jan 29, 2022 | $4.96M | Mar 28, 2023 |
| FY2021 | Jan 30, 2021 | $4.96M | Mar 28, 2022 |
| FY2020 | Feb 1, 2020 | $245.28M | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | $242.53M | Mar 31, 2020 |
| FY2018 | Feb 3, 2018 | $127.08M | Apr 3, 2019 |
| FY2017 | Jan 28, 2017 | $127.10M | Apr 4, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $421.21M | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $442.39M | Apr 2, 2026 |
| FY2024 | Feb 3, 2024 | $410.33M | Apr 1, 2025 |
| FY2023 | Jan 28, 2023 | $266.33M | Apr 2, 2024 |
| FY2022 | Jan 29, 2022 | $157.97M | Mar 28, 2023 |
| FY2021 | Jan 30, 2021 | $48.56M | Mar 28, 2022 |
| FY2020 | Feb 1, 2020 | $523.90M | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | $519.35M | Mar 31, 2020 |
| FY2018 | Feb 3, 2018 | $595.77M | Apr 3, 2019 |
| FY2017 | Jan 28, 2017 | $521.58M | Apr 4, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $29.77M | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $29.64M | Apr 2, 2026 |
| FY2024 | Feb 3, 2024 | $21.36M | Apr 1, 2025 |
| FY2023 | Jan 28, 2023 | $33.70M | Apr 2, 2024 |
| FY2022 | Jan 29, 2022 | $30.12M | Mar 28, 2023 |
| FY2021 | Jan 30, 2021 | $88.30M | Mar 28, 2022 |
| FY2020 | Feb 1, 2020 | $45.22M | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | $30.20M | Mar 31, 2020 |
| FY2019 | Feb 3, 2018 | $64.05M | Mar 31, 2020 |
| FY2019 | Jan 28, 2017 | $55.33M | Mar 31, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jan 29, 2022 | $0 | Mar 28, 2022 |
| FY2021 | Jan 30, 2021 | $198.85M | Mar 28, 2022 |
| FY2020 | Feb 1, 2020 | $198.39M | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | $197.93M | Mar 31, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 0 | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | 3 | Apr 2, 2026 |
| FY2025 | Feb 3, 2024 | 4 | Apr 2, 2026 |
| FY2024 | Jan 28, 2023 | 4 | Apr 1, 2025 |
| FY2023 | Jan 29, 2022 | 3 | Apr 2, 2024 |
| FY2022 | Jan 30, 2021 | (11) | Mar 28, 2023 |
| FY2019 | Feb 1, 2020 | 0 | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | 0 | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | 0 | Mar 31, 2020 |
| FY2019 | May 4, 2019 | 0 | Mar 31, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 0 | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | 3 | Apr 2, 2026 |
| FY2025 | Feb 3, 2024 | 4 | Apr 2, 2026 |
| FY2024 | Jan 28, 2023 | 4 | Apr 1, 2025 |
| FY2023 | Jan 29, 2022 | 3 | Apr 2, 2024 |
| FY2022 | Jan 30, 2021 | (11) | Mar 28, 2023 |
| FY2019 | Feb 1, 2020 | 0 | Mar 31, 2020 |
| FY2019 | Nov 2, 2019 | 0 | Mar 31, 2020 |
| FY2019 | Aug 3, 2019 | 0 | Mar 31, 2020 |
| FY2019 | May 4, 2019 | 0 | Mar 31, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 33.85M | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | 33.63M | Apr 2, 2026 |
| FY2024 | Feb 3, 2024 | 35.49M | Apr 1, 2025 |
| FY2023 | Jan 28, 2023 | 35.72M | Apr 2, 2024 |
| FY2022 | Jan 29, 2022 | 37.64M | Mar 28, 2023 |
| FY2021 | Jan 30, 2021 | 37.97M | Mar 28, 2022 |
| FY2020 | Feb 1, 2020 | 40.40M | Mar 30, 2021 |
| FY2019 | Feb 2, 2019 | 41.89M | Mar 31, 2020 |
| FY2018 | Feb 3, 2018 | 43.03M | Apr 3, 2019 |
| FY2017 | Jan 28, 2017 | 42.96M | Apr 4, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $9.45M | Apr 2, 2026 |
| FY2025 | Feb 1, 2025 | $9.69M | Apr 2, 2026 |
| FY2025 | Feb 3, 2024 | $9.95M | Apr 2, 2026 |
| FY2024 | Jan 28, 2023 | $10.18M | Apr 1, 2025 |
| FY2023 | Jan 29, 2022 | $10.65M | Apr 2, 2024 |
| FY2022 | Jan 30, 2021 | $10.76M | Mar 28, 2023 |
| FY2021 | Feb 1, 2020 | $11.42M | Mar 28, 2022 |
| FY2020 | Feb 2, 2019 | $11.98M | Mar 30, 2021 |
| FY2019 | Feb 3, 2018 | $12.03M | Mar 31, 2020 |
| FY2018 | Jan 28, 2017 | $12.10M | Apr 3, 2019 |